ANGPT1 and injury: In a severe acute lung injury (ALI) mouse model, treatment with bone marrow-derived MSCs modified to express human angiopoietin 1 (Ang1) promoted a significant reduction in airspace inflammation, with 96 % less neutrophils than groups treated with control MSCs or saline.